Numeric Investors’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Numeric Investors’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-87,600	Closed	-$647K	–	1291
2016 Q2	$647K	Buy	+87,600	New	+$657K	0.01%	679
2016 Q1	–	Sell	-87,700	Closed	-$548K	–	1223
2015 Q4	$548K	Buy	+87,700	New	+$576K	0.01%	705
2015 Q3	–	Sell	-18,200	Closed	-$151K	–	1261
2015 Q2	$151K	Sell	18,200 -80,200	-82%	-$709K	﹤0.01%	885
2015 Q1	$811K	Buy	+98,400	New	+$727K	0.01%	527
2014 Q3	–	Sell	-206,400	Closed	-$1.31M	–	999
2014 Q2	$1.31M	Buy	206,400 +85,400	+71%	+$587K	0.02%	385
2014 Q1	$975K	Buy	121,000 +29,500	+32%	+$230K	0.02%	452
2013 Q4	$624K	Buy	+91,500	New	+$494K	0.01%	551
2013 Q3	–	Sell	-10,840	Closed	-$190K	–	966
2013 Q2	$190K	Buy	+10,840	New	+$192K	﹤0.01%	725

Other funds holding ARIA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Numeric Investors's ARIA Position: Q3 2016 in Review

Numeric Investors sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2016, closing a stake of 87,600 shares — an estimated $647K sold.

Numeric Investors first reported a position in ARIA in Q2 2013 and held it in 8 quarters. The position peaked at $1.31M in Q2 2014. 202 funds tracked by Wall St. Rank hold ARIA as of Q3 2016.

Numeric Investors reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
Numeric Investors sold 87,600 Ariad Pharmaceuticals Inc shares in Q3 2016, an estimated $647K.
Numeric Investors first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 8 quarters.
Numeric Investors's Ariad Pharmaceuticals Inc position peaked at $1.31M in Q2 2014.
202 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2016.

Based on Numeric Investors's 13F filing for Q3 2016, filed 14 Nov 2016.